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in their cohort as greater urinary levels of vitamin D
metabolites have been observed in patients with abnormal
urinary protein excretion.4 Of note, Ishimura et al.5
reported, in 76 Japanese patients with CKD stage III and
IV, that diabetic patients had lower 25OHD levels than non-
diabetic (11.4±5.6 ng ml1 vs 22.3±9.4 ng ml1; Po0.0001).
Larger representative studies are necessary to evaluate the
prevalence of 25OHD deficiency across different ethnics
groups and levels of kidney dysfunction.
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Kosmadakis and co-workers have submitted a letter to
Kidney International that describes the results of a prevalent
cohort of 113 South East Asians and Caucasians with
chronic kidney disease 3 and 4. They describe in that cohort
a deficiency of 25 Vitamin D that is associated with hyper-
parathyroidism.1 As these data are essentially presented in
abstract form, as a letter, it is difficult to comment in detail.
The issue of ethnicity and Vitamin D levels is important
given the differential cardiovascular and bone disease
risks, which have been described in chronic kidney disease
in different ethnic groups. This short letter to the editor
does highlight the issue of ethnicity for the readership.
The SEEK paper2 reported results on a large cohort, which
included a substantial cohort of African Americans.
Differences in that cohort were also described, but were
not the major focus of the paper.
Of note, two manuscripts have been submitted, one from
the SEEK (US) database and one from a different Canadian
provincial database, which further address the issue of
ethnicity and differences in prevalence of abnormalities of
mineral metabolism. Together, these reports, including the
letter from these authors, suggest that the international
community need to review data in the context of ethnicity
so as to ensure robust conclusions and appropriate design of
therapeutic trials.
Larger studies are needed to investigate these asso-
ciations and their implications in chronic kidney disease
patients. The data to data differences are interesting and
suggestive, but a substantial amount of further research, in
both epidemiology and pathophysiology, is needed before
one advocates for large-scale therapeutic interventional
trials based on observations of single deficiencies.
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To the Editor: Lee et al.1 recently addressed the implications
for diabetic tubulopathy of reduced sodium-dependent
glucose transport across the proximal tubule brush border
membrane (BBM) during hyperglycemia. We believe that the
discussion gives an incomplete view of how BBM glucose
transport is influenced by diabetes mellitus.
Our own studies have failed to detect changes in sodium-
dependent glucose transport-mediated glucose uptake across
the BBM during experimental diabetes mellitus.2 Interestingly,
however, we found that diabetes promoted facilitated
(facilitated glucose transports (GLUT)-mediated) glucose
uptake across this membrane,2 this being largely due to an
eightfold increased BBM expression of GLUT2. Normalization
of plasma glucose reduced GLUT-mediated uptake and
GLUT2 expression to non-diabetic levels. Additional work3
implies that increased BBM levels of protein kinase C-b1
isoform may be involved in the diabetes-induced appearance
of GLUT2 at the BBM. Indeed, we found strong positive linear
correlations between plasma glucose level (5–40 mmol/l) and
BBM expression of both GLUT2 and protein kinase C-b1 and
between GLUT2 and protein kinase C-b1.
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